首页> 中文期刊> 《山东医药》 >非小细胞肺癌患者手术治疗前后外周血Th1、Th2、Th17细胞水平变化

非小细胞肺癌患者手术治疗前后外周血Th1、Th2、Th17细胞水平变化

         

摘要

目的 观察非小细胞肺癌(NSCLC)患者根治性手术治疗前后外周血中辅助性T淋巴细胞(Th)1、Th2、Th17细胞水平的变化.方法 用流式细胞仪检测27例NSCLC患者术前3 d及术后14 d外周血中的Th1、Th2、Th17细胞.结果 肺癌患者手术治疗前外周血中Th1为24.47%±10.34%、Th2为22.16%±9.98%、Th17为1.68%±1.10%,手术后分别为27.91%±7.06%、12.39%±7.84%、1.12%±0.46%;手术后Th2和Th17细胞水平与术前相比,P均<0.05.结论 NSCLC患者根治性手术治疗后外周血中Th1细胞水平升高,Th2、Th17细胞水平降低.%Objective To explore the change of Thl and Th2 and Thl7 in peripheral blood of patients with non-small cell lung cancer (NSCLC) pre- and postoperative. Method The Thl and Th2 and Thl7 in peripheral blood were examined in 27 patients with NSCLC on 3 days before operation and the 14th day after operation by FCM. Results The Th2 and Thl7 in postoperative were significantly lower than that in preoperative(22. 16% ± 9.98% vs 12.39% ± 7.84%,P <0.01; 1.68% ± 1.10% vs 1.12% ±0.46%, P <0.05). The Thl in postoperative were higher than that in preoperative,but there were no statistical significance (24.47% ±10.34% vs 27.91% ±7.06%, P>0.05). Conclusion After radical surgery treatment, the level of Thl cells in peripheral blood of patients with NSCLC is increased and the levels of Th2 and Thl7 cells are decreased.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号